How is significant clinical airflow limitation determined from pre- and postbronchodilator spirometry?
A) When the patient's FEF 25% to 27% increases by 12% and 200 mL/second
B) When the patient's FEV1 increases by 12%
C) When the FVC increases by 20% and 200 mL
D) When the FEV1/FVC ratio increases by 25%
Correct Answer:
Verified
Q11: Which of the following are considered phases
Q12: The respiratory therapist is performing an exercise
Q13: Which of the following is an exaggerated
Q14: Which of the following is con?
A) Adenovirus
B)
Q15: The therapist is asked to explain to
Q17: Which of the following pharmacologic agents may
Q18: Which of the following pathophysiologic events are
Q19: Which of the following spirometric measurements is
Q20: The therapist is asked to recommend a
Q21: What is typically the first pharmacologic intervention
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents